Inventor · disambiguated record
Paul Rubin
Also filed as: RUBIN PAUL · RUBIN PAUL D · RUBIN PAUL DAVID
38 granted patents·38 pending applications·571 citations·filing 1997–2024
98Inventor score
Top patents by PatentIndex Score
76 records- 0196US6458374B1Methods and compositions for treating chronic disorders using optically pure (+)-bupropionSEPRACOR INC·Filed 1999·Granted Oct 1, 2002·118 cites·17 claims
- 0295US6369079B1Methods for treating irritable bowel syndrome using optically pure (+) norcisaprideSEPRACOR INC·Filed 2000·Granted Apr 9, 2002·58 cites·10 claims
- 0392US6649183B2Methods for treating apnea and apnea disorders using optically pure R(+) ondansetronSEPRACOR INC·Filed 2001·Granted Nov 18, 2003·37 cites·16 claims
- 0491US6552045B2Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonistsSEPRACOR INC·Filed 2002·Granted Apr 22, 2003·27 cites·24 claims
- 0589US6548518B2Methods of treating gastro-esophogeal reflux disease using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonistsSEPRACOR INC·Filed 2002·Granted Apr 15, 2003·24 cites·24 claims
- 0688US6790849B2Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestantsSEPRACOR INC·Filed 2002·Granted Sep 14, 2004·18 cites·27 claims
- 0787US6835740B2Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisaprideSEPRACOR INC·Filed 2002·Granted Dec 28, 2004·18 cites·18 claims
- 0887US6339086B1Methods of making and using N-desmethylzopicloneSWPRACOR INC·Filed 2000·Granted Jan 15, 2002·25 cites·33 claims
- 0985US6353005B1Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonistSEPRACOR INC·Filed 2000·Granted Mar 5, 2002·12 cites·23 claims
- 1083US6548082B1Methods for treating apnea and apnea disorders using optically pure R(+) ondansetronSEPRACOR INC·Filed 2000·Granted Apr 15, 2003·13 cites·19 claims
- 1183US6362202B1Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonistsSEPRACOR INC·Filed 2000·Granted Mar 26, 2002·15 cites·16 claims
- 1282US6384038B1Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestantsSEPRACOR INC·Filed 1998·Granted May 7, 2002·46 cites·7 claims
- 1382US5900421AMethods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadineSEPRACOR INC·Filed 1997·Granted May 4, 1999·37 cites·18 claims
- 1481US6495605B2Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (+)-bupropionSEPRACOR INC·Filed 2001·Granted Dec 17, 2002·10 cites·62 claims
- 1580US10253101B2Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemiaXOMA US LLC·Filed 2016·Granted Apr 9, 2019·2 cites·33 claims
- 1680US6559165B1Methods for treating bulimia using optically pure (−) norcisaprideSEPRACOR INC·Filed 2000·Granted May 6, 2003·11 cites·10 claims
- 1777US6620851B2Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofenSEPRACOR INC·Filed 2002·Granted Sep 16, 2003·6 cites·13 claims
- 1874US6946464B2Methods of treating and preventing a convulsive stateSEPRACOR INC·Filed 2003·Granted Sep 20, 2005·5 cites·15 claims
- 1972US6506753B2Methods of making and using N-desmethylzopicloneSEPRACOR INC·Filed 2001·Granted Jan 14, 2003·4 cites·5 claims
- 2072US6458791B1Methods of treating muscle spasms using N-desmethylzopicloneSEPRACOR INC·Filed 2002·Granted Oct 1, 2002·4 cites·14 claims
- 2171US7030142B1Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolitesSEPRACOR INC·Filed 2000·Granted Apr 18, 2006·2 cites·19 claims
- 2271US6509353B1Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitorsSEPRACOR INC·Filed 2000·Granted Jan 21, 2003·3 cites·37 claims
- 2371US6362227B1Methods for the treatment of tinnitus and other disorders using R(−)ketoptofenSEPRACOR INC·Filed 2000·Granted Mar 26, 2002·3 cites·12 claims
- 2471US5962464AMethods and compositions for treating allergic asthma using descarboethoxyloratadineSEPRACOR INC·Filed 1998·Granted Oct 5, 1999·19 cites·8 claims
- 2570US6372197B1Methods and compositions using norastemizole in combination with leukotriene inhibitorsSEPRACOR INC·Filed 2000·Granted Apr 16, 2002·3 cites·12 claims
- 2666US10711067B2Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgeryXOMA US LLC·Filed 2016·Granted Jul 14, 2020·1 cites·24 claims
- 2765US2004171647A1S(-)rabeprazole compositions and methodsSEPRACOR INC·Filed 2004·Application pending·0 cites
- 2862US6054463AMethods for treating dermatitis using descarboethoxyloratadineSEPRACOR INC·Filed 1999·Granted Apr 25, 2000·11 cites·11 claims
- 2962US6048879AMethods for treating apnea, apnea disorders, bulimia, and other disorders using optically pure (+) norcisaprideSEPRACOR INC·Filed 1999·Granted Apr 11, 2000·11 cites·10 claims
- 3061US2004224989A1S-lansoprazole compositions and methodsFiled 2004·Application pending·0 cites
- 3160US2024366602A1Combination therapy of apelin receptor agonist and glp-1 receptor agonist for treating a disease or condition associated with weight gainBIOAGE LABS INC·Filed 2024·Application pending·0 cites
- 3260US2005154018A1Method for treating and preventing disorders using optically pure (+) norcisaprideSEPRACOR INC·Filed 2004·Application pending·0 cites
- 3357US2006025418A1Methods of making and using N-desmethylzopicloneSEPRACOR INC·Filed 2005·Application pending·0 cites
- 3457US2005032815A1Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestantsSEPRACOR INC·Filed 2004·Application pending·0 cites
- 3557US2005222211A1S(-)rabeprazole compositions and methodsSEPRACOR INC·Filed 2005·Application pending·0 cites
- 3656US6174902B1R-rabeprazole compositions and methodsSEPRACOR INC·Filed 1999·Granted Jan 16, 2001·16 cites·12 claims
- 3756US2004225020A1Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-) -bupropionSEPRACOR INC·Filed 2004·Application pending·0 cites
- 3855US6586437B2(S)-hydroxynefazodone antipsychotic therapySEPRACOR INC·Filed 2001·Granted Jul 1, 2003·0 cites·7 claims
- 3955US6469008B2(R)-hydroxynefazodone antipsychotic therapySEPRACOR INC·Filed 2001·Granted Oct 22, 2002·0 cites·7 claims
- 4055US2024122926A1Apelin receptor modulators for treating muscle conditionsBIOAGE LABS INC·Filed 2023·Application pending·0 cites
- 4155US2006142346A1S-lansoprazole compositions and methodsBARBERICH TIMOTHY J·Filed 2006·Application pending·0 cites
- 4254US8404715B2Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitorsRUBIN PAUL D·Filed 2012·Granted Mar 26, 2013·0 cites·15 claims
- 4354US7064138B2Methods for treating irritable bowel syndrome using optically pure (-) norcisaprideSEPRACOR INC·Filed 2003·Granted Jun 20, 2006·0 cites·10 claims
- 4454US6194431B1Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitorsFiled 1998·Granted Feb 27, 2001·7 cites·21 claims
- 4554US2003083343A1Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitorsSEPRACOR INC·Filed 2002·Application pending·0 cites
- 4654US2004019111A1Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofenSEPRACOR INC·Filed 2003·Application pending·0 cites
- 4754US2004058973A1Compositions for treating apnea and related disorders containing optically pure R(+) ondansetronSEPRACOR INC·Filed 2003·Application pending·0 cites
- 4854US2003109540A1Pharmaceutical dosage forms comprising descarboethoxyloratadineSEPRACOR INC·Filed 2002·Application pending·0 cites
- 4954US2003069280A1S(-)rabeprazole compositions and methodsSEPRACOR INC·Filed 2002·Application pending·0 cites
- 5053US2002115691A1S-rabeprazole compositions and methodsSEPRACOR INC·Filed 2002·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →